Subscribe To Our Free Newsletter |
Zydus receives USFDA approval for Theophylline ER Tablets
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Theophylline Extended-Release Tablets, 300 mg and 450 mg (USRLD: Theo-Dur Extended-Release Tablets).